Goodwin Procter LLP advised Personalized Media Communications on the deal. Personalized Media Communications (PMC) achieved a total victory in a patent infringement case against Apple, Inc.: Personalized Media Communications,...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Rubius Therapeutics on the deal. Rubius Therapeutics (NASDAQ: RUBY) announced the upsized underwritten public offering of 6,896,552 shares of its common stock at...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised the management team of Unit4 on the deal, Kirkland & Ellis advised TA Associates. Unit4, an enterprise software company principally owned by...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Vaccitech on the deal. Vaccitech announced the completion of its $168 million Series B, including the conversion of $43 million in convertible loan...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised the initial purchasers on the deal. Everbridge, Inc. (“Everbridge”) issued an aggregate of $375 million principal amount of its 0% Convertible Senior Notes...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Kosy Software Ltd on the deal. Kosy Software Ltd announced its seed financing round led by Picus Capital GmbH. Kosy is an...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised the initial purchasers on the deal. Cutera, Inc. (the “Company”) entered into a purchase agreement (the “Purchase Agreement”) with Stifel, Nicolaus & Company,...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised ElevateBio on the deal. ElevateBio, a cell and gene therapy technology company focused on powering transformative cell and gene therapies, announced it...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised the initial purchasers on the deal. MannKind Corporation (the “Company”) completed its previously announced private offering (the “Offering”) of $200.0 million aggregate...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Allen & Overy, Deloitte Tax & Legal, Goodwin Procter, Weil, Gotshal & Manges, advised on the matter. Allen & Overy advised Apax Partners with...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Monte Rosa Therapeutics on the deal. Monte Rosa Therapeutics, a biotechnology company focused on discovering and developing precision medicines that degrade disease-causing...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Tessera Therapeutics on the deal. Tessera Therapeutics, an early-stage life sciences company founded by Flagship Pioneering, announced today that it has raised...
You must be a Standard 1 Year member to access this content.
